Radiation Oncology/Therapy: Page 11

Radiomics for dummies: French team bids to make tricky topic easy

By Edna Astbury-Ward, PhD

Researchers from one of Europe's leading cancer facilities, the Gustave Roussy Institute in Paris, have attempted to boost understanding of the notoriously difficult subject known as radiomics. They've outlined the five steps needed to validate an imaging biomarker.

April 11, 2022

Sun Nuclear releases SaaS option for SunCheck

By AuntMinnieEurope.com staff writers

Radiation oncology quality-assurance technology developer Sun Nuclear has released a cloud-hosted software-as-a-service (SaaS) option for its SunCheck radiation therapy quality assurance management platform.

April 10, 2022

German group highlights clinical potential of novel PET radiotracer

By Will Morton

Scientists from Cologne have tested an experimental zirconium-89-based prostate-specific membrane antigen (PSMA) PET radiotracer and found it detected PSMA-positive lesions in more than half of patients who had previous negative scans with established tracers.

April 10, 2022

IBA to partner with Dutch hospital on breast cancer research

By AuntMinnieEurope.com staff writers

Proton therapy developer Ion Beam Applications (IBA) and the University Medical Center Groningen in the Netherlands will collaborate on research into flash radiation therapy for breast cancer.

April 5, 2022

RCR president responds to cancer services report

By AuntMinnieEurope.com staff writers

The head of the Royal College of Radiologists (RCR) has responded to the U.K. Health and Social Care Committee's recent cancer services report, which warned that a lack of "serious effort" on alleviating workforce shortages risks patient survival rates.

April 4, 2022

GE joins forces with Elekta in radiation oncology

By AuntMinnieEurope.com staff writers

GE Healthcare and radiation oncology firm Elekta have signed a global commercial collaboration agreement.

April 4, 2022

New form of MRI causes cancerous prostate tissue to glow

By AuntMinnieEurope.com staff writers

A new type of MRI protocol called synthetic correlated diffusion imaging better visualizes cancerous tissue in the prostate and may help clinicians better identify and track cancer over time, according to a study published on 1 March in Scientific Reports.

March 27, 2022

Eckert & Ziegler partners with Alpha-9 Theranostics

By AuntMinnieEurope.com staff writers

Isotope technology firm Eckert & Ziegler has agreed to supply lutetium-177 to the Canadian biotechnology firm Alpha-9 Theranostics for use in clinical trials.

March 27, 2022

ITM promotes supply deal with Novartis for Pluvicto

By AuntMinnieEurope.com staff writers

German radiopharmaceutical firm ITM Isotope Technologies Munich SE (ITM) highlighted its lutetium-177 supply deal with Novartis in the wake of the U.S. Food and Drug Administration's approval of the company's Pluvicto radioligand therapy.

March 24, 2022

Bracco, Philochem work together to develop small molecule

By AuntMinnieEurope.com staff writers

Bracco is collaborating with fellow Italian firm Philochem to develop and commercialize a small organic molecule for diagnostic imaging applications.

March 22, 2022

FluoGuide gives details on brain cancer research in Denmark

By AuntMinnieEurope.com staff writers

FluoGuide said a research grant connected to its work with Rigshospitalet in Copenhagen, Denmark, will help it set up a phase II trial for the company's FG001 radiopharmaceutical candidate in patients with less aggressive brain cancers.

March 20, 2022

Dutch isotope reactor restarts

By AuntMinnieEurope.com staff writers

The High Flux Reactor (HFR) in Petten, the Netherlands, has restarted after a forced shutdown due to a water leak in January, with isotopes deliveries to hospitals expected within two weeks.

March 17, 2022

Previous Page

Page 11 of 126

Next Page